BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 32195300)

  • 1. An
    Ashokkumar M; Sonawane A; Sathiyamani B; Esakialraj L BH; Hanna LE
    Data Brief; 2020 Apr; 29():105365. PubMed ID: 32195300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.
    Ashokkumar M; Aralaguppe SG; Tripathy SP; Hanna LE; Neogi U
    J Virol; 2018 May; 92(9):. PubMed ID: 29491151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha.
    Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
    Sci Rep; 2020 Feb; 10(1):2747. PubMed ID: 32066770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ADS-J1 antagonizes semen-derived enhancer of virus infection-mediated enhancement of transmitted founder HIV-1 and its matched chronic control strain infection].
    Liu HM; Ma NN; Luo C; Yuan SY; Liu FL; Yao XG; Zhou CQ; Zou M
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):211-216. PubMed ID: 29502062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness.
    Sugrue E; Wickenhagen A; Mollentze N; Aziz MA; Sreenu VB; Truxa S; Tong L; da Silva Filipe A; Robertson DL; Hughes J; Rihn SJ; Wilson SJ
    PLoS Pathog; 2022 Nov; 18(11):e1010973. PubMed ID: 36399512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection.
    Kumata R; Iwanami S; Mar KB; Kakizoe Y; Misawa N; Nakaoka S; Koyanagi Y; Perelson AS; Schoggins JW; Iwami S; Sato K
    PLoS Comput Biol; 2022 Apr; 18(4):e1010053. PubMed ID: 35468127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences.
    Song H; Hora B; Giorgi EE; Kumar A; Cai F; Bhattacharya T; Perelson AS; Gao F
    Sci Rep; 2016 Dec; 6():38130. PubMed ID: 27909304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.
    Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
    Scarlatti G
    AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.
    Kafando A; Martineau C; El-Far M; Fournier E; Doualla-Bell F; Serhir B; Kazienga A; Sangaré MN; Sylla M; Chamberland A; Charest H; Tremblay CL
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31683782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.
    Kozak SL; Platt EJ; Madani N; Ferro FE; Peden K; Kabat D
    J Virol; 1997 Feb; 71(2):873-82. PubMed ID: 8995603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.
    Stoddard MB; Li H; Wang S; Saeed M; Andrus L; Ding W; Jiang X; Learn GH; von Schaewen M; Wen J; Goepfert PA; Hahn BH; Ploss A; Rice CM; Shaw GM
    mBio; 2015 Feb; 6(2):e02518. PubMed ID: 25714714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
    Beretta M; Moreau A; Bouvin-Pley M; Essat A; Goujard C; Chaix ML; Hue S; Meyer L; Barin F; Braibant M;
    AIDS; 2018 Sep; 32(14):1917-1926. PubMed ID: 29927786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
    Kumar A; Smith CEP; Giorgi EE; Eudailey J; Martinez DR; Yusim K; Douglas AO; Stamper L; McGuire E; LaBranche CC; Montefiori DC; Fouda GG; Gao F; Permar SR
    PLoS Pathog; 2018 Apr; 14(4):e1006944. PubMed ID: 29672607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes.
    Peters PJ; Gonzalez-Perez MP; Musich T; Moore Simas TA; Lin R; Morse AN; Shattock RJ; Derdeyn CA; Clapham PR
    Retrovirology; 2015 Jun; 12():48. PubMed ID: 26055104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
    Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.